1. Home
  2. REED vs LEXX Comparison

REED vs LEXX Comparison

Compare REED & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reed's Inc.

REED

Reed's Inc.

HOLD

Current Price

$1.08

Market Cap

9.1M

Sector

N/A

ML Signal

HOLD

Logo Lexaria Bioscience Corp.

LEXX

Lexaria Bioscience Corp.

HOLD

Current Price

$10.60

Market Cap

8.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REED
LEXX
Founded
1987
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.1M
8.7M
IPO Year
2009
2011

Fundamental Metrics

Financial Performance
Metric
REED
LEXX
Price
$1.08
$10.60
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.50
AVG Volume (30 Days)
6.7K
92.8K
Earning Date
05-12-2026
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$34,065,000.00
$705,923.00
Revenue This Year
$18.74
N/A
Revenue Next Year
$18.00
$601.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
52.05
52 Week Low
$0.73
$0.35
52 Week High
$5.97
$12.89

Technical Indicators

Market Signals
Indicator
REED
LEXX
Relative Strength Index (RSI) 52.80 83.12
Support Level $0.76 $0.65
Resistance Level $1.42 N/A
Average True Range (ATR) 0.11 1.01
MACD 0.04 0.40
Stochastic Oscillator 69.59 69.36

Price Performance

Historical Comparison
REED
LEXX

About REED Reed's Inc.

Reed's Inc is a branded beverage company offering a portfolio of natural, premium, and functional beverages under the Reed's and Virgil's brands. The company's portfolio of handcrafted, all-natural beverages is sold in outlets nationwide, including the natural and specialty food channel, grocery stores, mass merchants, drug stores, convenience stores, club stores, and on-premise locations, including bars and restaurants. The company operates in a single reportable segment, which consists of manufacturing carbonated beverages under Reed's and Virgil's brand names.

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.

Share on Social Networks: